Global Cancer Testing/Screening Market Size, Status and Forecast 2019-2025

Description

Screening means checking your body for cancer before you have symptoms.
In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.
In 2018, the global Cancer Testing/Screening market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Testing/Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Testing/Screening development in United States, Europe and China.

The key players covered in this study
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories

Market segment by Type, the product can be split into
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Testing/Screening status, future forecast, growth opportunity, key market and key players.
To present the Cancer Testing/Screening development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Testing/Screening are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Testing/Screening Market Size Growth Rate by Type (2014-2025)
1.4.2 Lung Cancer
1.4.3 Blood Cancer
1.4.4 Bone Cancer
1.4.5 Gall Bladder Cancer
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Testing/Screening Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Testing/Screening Market Size
2.2 Cancer Testing/Screening Growth Trends by Regions
2.2.1 Cancer Testing/Screening Market Size by Regions (2014-2025)
2.2.2 Cancer Testing/Screening Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Testing/Screening Market Size by Manufacturers
3.1.1 Global Cancer Testing/Screening Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Testing/Screening Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Testing/Screening Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Testing/Screening Key Players Head office and Area Served
3.3 Key Players Cancer Testing/Screening Product/Solution/Service
3.4 Date of Enter into Cancer Testing/Screening Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cancer Testing/Screening Market Size by Type (2014-2019)
4.2 Global Cancer Testing/Screening Market Size by Application (2014-2019)

5 United States
5.1 United States Cancer Testing/Screening Market Size (2014-2019)
5.2 Cancer Testing/Screening Key Players in United States
5.3 United States Cancer Testing/Screening Market Size by Type
5.4 United States Cancer Testing/Screening Market Size by Application

6 Europe
6.1 Europe Cancer Testing/Screening Market Size (2014-2019)
6.2 Cancer Testing/Screening Key Players in Europe
6.3 Europe Cancer Testing/Screening Market Size by Type
6.4 Europe Cancer Testing/Screening Market Size by Application

7 China
7.1 China Cancer Testing/Screening Market Size (2014-2019)
7.2 Cancer Testing/Screening Key Players in China
7.3 China Cancer Testing/Screening Market Size by Type
7.4 China Cancer Testing/Screening Market Size by Application

8 Japan
8.1 Japan Cancer Testing/Screening Market Size (2014-2019)
8.2 Cancer Testing/Screening Key Players in Japan
8.3 Japan Cancer Testing/Screening Market Size by Type
8.4 Japan Cancer Testing/Screening Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cancer Testing/Screening Market Size (2014-2019)
9.2 Cancer Testing/Screening Key Players in Southeast Asia
9.3 Southeast Asia Cancer Testing/Screening Market Size by Type
9.4 Southeast Asia Cancer Testing/Screening Market Size by Application

10 India
10.1 India Cancer Testing/Screening Market Size (2014-2019)
10.2 Cancer Testing/Screening Key Players in India
10.3 India Cancer Testing/Screening Market Size by Type
10.4 India Cancer Testing/Screening Market Size by Application

11 Central & South America
11.1 Central & South America Cancer Testing/Screening Market Size (2014-2019)
11.2 Cancer Testing/Screening Key Players in Central & South America
11.3 Central & South America Cancer Testing/Screening Market Size by Type
11.4 Central & South America Cancer Testing/Screening Market Size by Application

12 International Players Profiles
12.1 Dias Orin
12.1.1 Dias Orin Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Testing/Screening Introduction
12.1.4 Dias Orin Revenue in Cancer Testing/Screening Business (2014-2019)
12.1.5 Dias Orin Recent Development
12.2 Epigenetics
12.2.1 Epigenetics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Testing/Screening Introduction
12.2.4 Epigenetics Revenue in Cancer Testing/Screening Business (2014-2019)
12.2.5 Epigenetics Recent Development
12.3 Techlab
12.3.1 Techlab Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Testing/Screening Introduction
12.3.4 Techlab Revenue in Cancer Testing/Screening Business (2014-2019)
12.3.5 Techlab Recent Development
12.4 Positive Bioscience
12.4.1 Positive Bioscience Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Testing/Screening Introduction
12.4.4 Positive Bioscience Revenue in Cancer Testing/Screening Business (2014-2019)
12.4.5 Positive Bioscience Recent Development
12.5 Genextropy
12.5.1 Genextropy Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Testing/Screening Introduction
12.5.4 Genextropy Revenue in Cancer Testing/Screening Business (2014-2019)
12.5.5 Genextropy Recent Development
12.6 M Genomics
12.6.1 M Genomics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Testing/Screening Introduction
12.6.4 M Genomics Revenue in Cancer Testing/Screening Business (2014-2019)
12.6.5 M Genomics Recent Development
12.7 20/20 GeneSystems
12.7.1 20/20 GeneSystems Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Testing/Screening Introduction
12.7.4 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2014-2019)
12.7.5 20/20 GeneSystems Recent Development
12.8 AB SCIEX
12.8.1 AB SCIEX Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Testing/Screening Introduction
12.8.4 AB SCIEX Revenue in Cancer Testing/Screening Business (2014-2019)
12.8.5 AB SCIEX Recent Development
12.9 Abbott Laboratories
12.9.1 Abbott Laboratories Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Testing/Screening Introduction
12.9.4 Abbott Laboratories Revenue in Cancer Testing/Screening Business (2014-2019)
12.9.5 Abbott Laboratories Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Choose License Type

Checkout Inquiry Sample